Literature DB >> 8474531

Dialysable leukocyte extracts modify the course of experimental paracoccidioidomycosis in the Syrian hamster.

M T Peraçoli1, M T Rezkallah-Iwasso, N G Mota, M R Montenegro.   

Abstract

The effect of dialysable leukocyte extracts (DLE) obtained from hamsters immunized with Paracoccidioides brasiliensis (immune DLE) and from non-immunized hamsters (non-immune DLE) was studied in hamsters inoculated with P. brasiliensis by the intratesticular route. Treatment with immune or non-immune DLE was started during the third week of infection and was repeated at 7, 11, 15 and 19 weeks. A group of untreated infected animals was used as control. Animals were submitted to the delayed hypersensitivity skin test to P. brasiliensis antigen (PbAg) in vivo and assayed in vitro by the macrophage migration inhibition test in the presence of Phytohemagglutinin (PHA) and PbAg and by immunodiffusion for specific antibody. The animals were sacrificed at 4, 8, 12, 16 and 20 weeks. The morphology and extension of the lesions were studied at the inoculation site, and in lymph nodes, lungs, liver, spleen and kidneys. In contrast to the controls, animals treated with both DLEs maintained a positive cell-mediated immune response throughout the experiment and developed less extensive infection with a significantly lower number of fungi in the lesions. The results suggest that immune and non-immune DLE preparations modified the evolution of experimental paracoccidioidomycosis with equal efficiency. This similarity may be explained by the immunoregulatory activities of both extracts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474531     DOI: 10.1007/bf01104070

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  37 in total

1.  Bovine transfer factor: in vivo transfer of cell-mediated immunity to cattle with alcohol precipitates.

Authors:  P H Klesius; H H Fudenberg
Journal:  Clin Immunol Immunopathol       Date:  1977-09

2.  The possible role of circulating immune complexes in the deficiency of cell-mediated immunity in paracoccidioidomycosis.

Authors:  D Chequer-Bou-Habib; M P Oliveira-Neto; M F Ferreira-da-Cruz; B Galvão-Castro
Journal:  Braz J Med Biol Res       Date:  1989       Impact factor: 2.590

3.  [The polysaccharidic antigen from Paracoccidioides brasiliensis. Study of the time of cultivation necessary for the preparation of the antigen].

Authors:  C F Netto; V S Vegas; I M Sciannaméa; D B Guarnieri
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1969 May-Jun       Impact factor: 1.846

4.  Disseminated Cryptococcus treated with transfer factor.

Authors:  P A Gross; C Patel; L E Spitler
Journal:  JAMA       Date:  1978-11-24       Impact factor: 56.272

5.  Transfer of osteosarcoma-specific cell-mediated immunity in hamsters by rabbit dialyzable leukocyte extracts.

Authors:  K Y Tsang; H H Fudenberg; J F Pan
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

6.  Clinical and immunologic response to antigen-specific transfer factor in drug-resistant infection with Mycobacterium xenopi.

Authors:  J M Dwyer; B J Gerstenhaber; K J Dobuler
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

7.  Modification of an experimental mouse Candida infection by human dialyzable leukocyte extract.

Authors:  P Sen; J K Smith; M Buse; H C Hsieh; M A Lavenhar; D Lintz; D B Louria
Journal:  Sabouraudia       Date:  1982-06

8.  Ultrastructure of lymphocytes from patients with paracoccidioidomycosis in the lymphocyte transformation test by phytohemagglutinin.

Authors:  J C Da Costa; R P Conçalves; P M Pagnano; L M Bechelli
Journal:  Mycopathologia       Date:  1986-03       Impact factor: 2.574

9.  Guidelines for immunotherapy of antigen-specific defects with transfer factor.

Authors:  G B Wilson; H H Fudenberg; R H Keller
Journal:  J Clin Lab Immunol       Date:  1984-02

10.  Accessory function of interleukin-1 and interleukin-6: preferential costimulation of T4 positive lymphocytes.

Authors:  G Tosato; J Miller; G Marti; S E Pike
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.